Suchergebnisse - "Tamura, Tomohide"

PubPharm (34)

1

First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer : Updated survival analysis of the ONO-4538-52/TASUKI-52 randomized controlled trial

enthalten in: Cancer medicine | 2023

von Kim, H. | Sugawara, S. | Lee, J. | +15

2

Phase I study of TAS-121, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with non-small-cell lung cancer harboring EGFR mutations

enthalten in: Investigational new drugs | 2019

von Nishio, M. | Murakami, H. | Ohe, Y. | +11

3

Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer

enthalten in: International journal of clinical oncology | 2017

von Yamamoto, N. | Goto, K. | Nishio, M. | +9

ErratumIn: Int J Clin Oncol. 2017 Feb;22(1):79. - PMID 27747455

4

Phase I study of the second-generation, recombinant, human EGFR antibody necitumumab in Japanese patients with advanced solid tumors

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Tamura, Y. | Nokihara, H. | Honda, K. | +7

5

Erlotinib for Japanese patients with activating EGFR mutation-positive non-small-cell lung cancer : combined analyses from two Phase II studies

enthalten in: Future oncology (London, England) | 2016

von Atagi, S. | Goto, K. | Seto, T. | +4

6

Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating tumor cells

enthalten in: Cancer science | 2016

von Sawada, T. | Watanabe, M. | Fujimura, Y. | +10

7

Analysis of Epidermal Growth Factor Receptor Mutations in Serum Among Japanese Patients Treated With First-Line Erlotinib for Advanced Non-Small-Cell Lung Cancer

enthalten in: Clinical lung cancer | 2016

von Nishio, M. | Goto, K. | Chikamori, K. | +5

8

Cytotoxic chemotherapy may overcome the development of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) therapy

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2015

von Kanda, S. | Horinouchi, H. | Fujiwara, Y. | +7

9

Phase I study of the HER3-targeted antibody patritumab (U3-1287) combined with erlotinib in Japanese patients with non-small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2015

von Nishio, M. | Horiike, A. | Murakami, H. | +7

10

Epidermal growth factor receptor mutation is associated with longer local control after definitive chemoradiotherapy in patients with stage III nonsquamous non-small-cell lung cancer

enthalten in: International journal of radiation oncology, biology, physics | 2015

von Yagishita, S. | Horinouchi, H. | Katsui Taniyama, T. | +13